PRIMARY IMPLANTATION OF ANTIARRHYTHMIC DEVICES WITHOUT USE OF FLUOROSCOPY
Abstract
To assess effectiveness and safety of implantation of antiarrhythmic devices under intracardiac echocardiographic guidance in March 2014 through September 2015, 80 patients aged 53.4±9.1 years were examined and treated.
About the Authors
E. B. Kropotkin
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
E. A. Ivanitskiy
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
D. A. Shlyakov
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
A. A. Vyrva
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
V. Yu. Tsivkovskiy
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
A. V. Aksenovskiy
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
M. I. Gankin
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
D. V. Drobot
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
V. A. Sakovich
Федеральный центр сердечно-сосудистой хирургии
Russian Federation
Russian Federation
References
1. Greenspon A.J., Jasmine D., et al. Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009: increasing complexity of patients and procedures // J Am Coll Cardiol. 2012; 60(16): 1540-1545.
2. Kurtz S.M., Ochoa J.A., Lau E., et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1992-2006 // Pacing Clin Electrophysiol 2010; 33: 705-11.
3. Wagner L.K., Eifel P.J., Geise R.A. Potential biological effects fol- lowing high X-ray dose interventional procedures. J Vasc Interv Radiol 1994; 5: 71-84.
4. Food and Drug Administration. Avoidance of Serious X-Ray Induced Skin Injuries to Patients During Fluoroscopically-Guided Procedures. Rockville, MD, USA: Food and Drug Administration; 1994.
5. Rougin A, Goldstein J, Bar O, et al. Brain and neck tumors among physicians performing interventional procedures // J Am Cardiol 2013; 9: 1368-72.
6. Al-Bawardy R. et al. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: A comprehensive review // Clinical Cardiology. - 2013. -Vol. 36 - P. 249-254.
7. Tuzcu V, Kilinc OU. Implantable Cardioverter Defibrillator Implantation without Using Fluoroscopy in a Pregnant Patient // Pacing Clin Electrophysiol 2011 Sep 28.
8. Богачевский А.Н., Богачевская С.А., Бондарь В.Ю. Имплантация постоянных кардиостимуляторов под ультразвуковым контролем // Вестник аритмологии 2014. - N 78. - С. 42-46.
9. Klustein M., Balkin J., Butnaru A., et al. Tricuspid incompetence following permanent pacemaker implantation // Pacing Clin Electrophysiology. 2009; 32: 135 - 137.
10. Celiker C., Kucukoglu M.S., Arat-Ozkan A. et al. Right ventricularand tricuspid valve function in patients with two ventricular pacemaker leads // Japan Heart Journal. 2004; 45: 103-108.
Review
For citations:
Kropotkin E.B., Ivanitskiy E.A., Shlyakov D.A., Vyrva A.A., Tsivkovskiy V.Yu., Aksenovskiy A.V., Gankin M.I., Drobot D.V., Sakovich V.A. PRIMARY IMPLANTATION OF ANTIARRHYTHMIC DEVICES WITHOUT USE OF FLUOROSCOPY. Journal of Arrhythmology. 2015;(81):5-9. (In Russ.)
Views:
150
Email this article 